Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Author Correction: Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis.

Erichsen L, Ghanjati F, Beermann A, Poyet C, Hermanns T, Schulz WA, Seifert HH, Wild PJ, Buser L, Kröning A, Braunstein S, Anlauf M, Jankowiak S, Hassan M, Bendhack ML, Araúzo-Bravo MJ, Santourlidis S.

Sci Rep. 2018 Apr 11;8(1):6051. doi: 10.1038/s41598-018-23158-z.

2.

Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis.

Erichsen L, Ghanjati F, Beermann A, Poyet C, Hermanns T, Schulz WA, Seifert HH, Wild PJ, Buser L, Kröning A, Braunstein S, Anlauf M, Jankowiak S, Hassan M, Bendhack ML, Araúzo-Bravo MJ, Santourlidis S.

Sci Rep. 2018 Feb 22;8(1):3477. doi: 10.1038/s41598-018-21932-7. Erratum in: Sci Rep. 2018 Apr 11;8(1):6051.

3.

Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model.

Benten D, Behrang Y, Unrau L, Weissmann V, Wolters-Eisfeld G, Burdak-Rothkamm S, Stahl FR, Anlauf M, Grabowski P, Möbs M, Dieckhoff J, Sipos B, Fahl M, Eggers C, Perez D, Bockhorn M, Izbicki JR, Lohse AW, Schrader J.

Mol Cancer Res. 2018 Mar;16(3):496-507. doi: 10.1158/1541-7786.MCR-17-0163. Epub 2018 Jan 12.

PMID:
29330294
4.

Blutdruckmessungen zur Hochdruckbekämpfung sollten i.d.R. mit Automaten erfolgen.

Anlauf M, Weber F.

Dtsch Med Wochenschr. 2018 Jan;143(1):59-60. doi: 10.1055/s-0043-120941. Epub 2018 Jan 9. German. No abstract available.

PMID:
29316586
5.

Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains.

Nieser M, Henopp T, Brix J, Stoß L, Sitek B, Naboulsi W, Anlauf M, Schlitter AM, Klöppel G, Gress T, Moll R, Bartsch DK, Heverhagen AE, Knoefel WT, Kaemmerer D, Haybaeck J, Fend F, Sperveslage J, Sipos B.

Neuroendocrinology. 2017;104(3):302-312. doi: 10.1159/000446917. Epub 2016 May 25.

PMID:
27222126
6.

The German Hypertension League (Deutsche Hochdruckliga) Quality Seal Protocol for blood pressure-measuring devices: 15-year experience and results from 105 devices for home blood pressure control.

Tholl U, Lüders S, Bramlage P, Dechend R, Eckert S, Mengden T, Nürnberger J, Sanner B, Anlauf M.

Blood Press Monit. 2016 Aug;21(4):197-205. doi: 10.1097/MBP.0000000000000186.

PMID:
26998590
7.

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.

Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B, Sedlackova E, Toumpanakis C, Anlauf M, Cwikla JB, Caplin M, O'Toole D, Perren A; Vienna Consensus Conference participants.

Neuroendocrinology. 2016;103(2):186-94. doi: 10.1159/000443172. Epub 2016 Jan 5. No abstract available.

8.

Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.

Rosentraeger MJ, Garbrecht N, Anlauf M, Raffel A, Knoefel WT, Wiedenmann B, Klöppel G.

Virchows Arch. 2016 Mar;468(3):277-87. doi: 10.1007/s00428-015-1890-9. Epub 2015 Dec 9.

PMID:
26649731
9.

[Under discussion: Basic principles of scientific pharmacotherapy - stochastic evidence and effectiveness models].

Anlauf M.

Z Evid Fortbild Qual Gesundhwes. 2015;109(3):257-61. doi: 10.1016/j.zefq.2015.05.001. Epub 2015 Jun 18. German. No abstract available.

PMID:
26189177
10.

[The so-called complementary-alternative medicine (CAM) - reflections on an old but still current topic].

Anlauf M, Köbberling J.

Z Evid Fortbild Qual Gesundhwes. 2015;109(3):235. doi: 10.1016/j.zefq.2015.05.002. Epub 2015 Jun 18. German. No abstract available.

PMID:
26189174
11.

Complementary and alternative drug therapy versus science-oriented medicine.

Anlauf M, Hein L, Hense HW, Köbberling J, Lasek R, Leidl R, Schöne-Seifert B.

Ger Med Sci. 2015 Jun 23;13:Doc05. doi: 10.3205/000209. eCollection 2015.

12.

Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1.

Bartsch DK, Albers MB, Lopez CL, Apitzsch JC, Walthers EM, Fink L, Fendrich V, Slater EP, Waldmann J, Anlauf M.

Neuroendocrinology. 2016;103(3-4):240-7. doi: 10.1159/000435921. Epub 2015 Jun 18.

PMID:
26113081
13.

[Neuroendocrine neoplasms of the breast].

Anlauf M, Neumann M, Bomberg S, Luczak K, Heikaus S, Gustmann C, Antke C, Ezziddin S, Fottner C, Pavel M, Pape UF, Rinke A, Lahner H, Schott M, Cremer B, Hörsch D, Baum RP, Groh U, Alkatout I, Rudlowski C, Scheler P, Zirbes TK, Hoffmann J, Fehm T, Gabbert HE, Baldus SE.

Pathologe. 2015 May;36(3):261-70. doi: 10.1007/s00292-015-0024-0. Review. German.

PMID:
25986886
14.

In reply.

Weber F, Anlauf M.

Dtsch Arztebl Int. 2015 Feb 13;112(7):120. doi: 10.3238/arztebl.2015.0120b. No abstract available.

15.

Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations.

Sipos B, Sperveslage J, Anlauf M, Hoffmeister M, Henopp T, Buch S, Hampe J, Weber A, Hammel P, Couvelard A, Höbling W, Lieb W, Boehm BO, Klöppel G.

J Clin Endocrinol Metab. 2015 May;100(5):E783-8. doi: 10.1210/jc.2014-4405. Epub 2015 Feb 19.

PMID:
25695890
16.

Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.

Schemenau J, Baldus S, Anlauf M, Reinecke P, Braunstein S, Blum S, Nachtkamp K, Neukirchen J, Strup C, Aul C, Haas R, Gattermann N, Germing U.

Eur J Haematol. 2015 Sep;95(3):181-9. doi: 10.1111/ejh.12512. Epub 2015 May 15. Review.

PMID:
25600827
17.

Treatment resistant hypertension--investigation and conservative management.

Weber F, Anlauf M.

Dtsch Arztebl Int. 2014 Jun 20;111(25):425-31. doi: 10.3238/arztebl.2014.0425. Review.

18.

Somatostatin receptor imaging-guided pasireotide therapy in medullary thyroid cancer with ectopic adrenocorticotropin production.

Verburg FA, Anlauf M, Mottaghy FM, Karges W.

Clin Nucl Med. 2015 Jan;40(1):e83-4. doi: 10.1097/RLU.0000000000000522.

PMID:
24999678
19.

Novel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomas.

Alkatout I, Friemel J, Sitek B, Anlauf M, Eisenach PA, Stühler K, Scarpa A, Perren A, Meyer HE, Knoefel WT, Klöppel G, Sipos B.

Mod Pathol. 2015 Jan;28(1):69-79. doi: 10.1038/modpathol.2014.82. Epub 2014 Jun 20.

20.

Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany.

Hörsch D, Schmid KW, Anlauf M, Darwiche K, Denecke T, Baum RP, Spitzweg C, Grohé C, Presselt N, Stremmel C, Heigener DF, Serke M, Kegel T, Pavel M, Waller CF, Deppermann KM, Arnold R, Huber RM, Weber MM, Hoffmann H.

Oncol Res Treat. 2014;37(5):266-76. doi: 10.1159/000362430. Epub 2014 Apr 14. Review.

PMID:
24853787
21.

Hyperplasia to neoplasia sequence of duodenal and pancreatic neuroendocrine diseases and pseudohyperplasia of the PP-cells in the pancreas.

Klöppel G, Anlauf M, Perren A, Sipos B.

Endocr Pathol. 2014 Jun;25(2):181-5. doi: 10.1007/s12022-014-9317-8. Review.

PMID:
24718881
22.

[Neuroendocrine neoplasms of the distal jejunum and ileum].

Anlauf M, Sipos B, Boeck I, Baldus SE, Heikaus S, Krausch M, Knoefel WT, Begum N, Goretzki P, Schott M, Auernhammer CJ, Cremer B, Rinke A, Ezziddin S, Fottner C, Pöpperl G, Lahner H, Hörsch D, Gabbert HE, Komminoth P, Perren A, Klöppel G, Wiedenmann B, Pavel M, Pape U.

Pathologe. 2014 May;35(3):283-93; quiz 294. doi: 10.1007/s00292-013-1888-5. Review. German.

PMID:
24671468
23.

New model for gastroenteropancreatic large-cell neuroendocrine carcinoma: establishment of two clinically relevant cell lines.

Krieg A, Mersch S, Boeck I, Dizdar L, Weihe E, Hilal Z, Krausch M, Möhlendick B, Topp SA, Piekorz RP, Huckenbeck W, Stoecklein NH, Anlauf M, Knoefel WT.

PLoS One. 2014 Feb 14;9(2):e88713. doi: 10.1371/journal.pone.0088713. eCollection 2014.

24.

Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality.

Cupisti K, Lehwald N, Anlauf M, Riemer J, Werner TA, Krieg A, Witte J, Chanab A, Baldus SE, Krausch M, Raffel A, Herdter C, Schott M, Knoefel WT.

Horm Metab Res. 2014 Feb;46(2):138-44. doi: 10.1055/s-0033-1361158. Epub 2013 Dec 19.

PMID:
24356791
25.

"Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.

Krausch M, Raffel A, Anlauf M, Schott M, Lehwald N, Krieg A, Topp SA, Cupisti K, Knoefel WT.

World J Surg. 2014 Feb;38(2):392-401. doi: 10.1007/s00268-013-2267-3.

PMID:
24101025
26.

Is minimal residual lymph node disease in papillary thyroid cancer of prognostic impact? An analysis of the epithelial cell adhesion molecule EpCAM in lymph nodes of 40 pN0 patients.

Rehders A, Anlauf M, Adamowsky I, Ghadimi MH, Klein S, Antke C, Cupisti K, Stoecklein NH, Knoefel WT.

Pathol Oncol Res. 2014 Jan;20(1):185-90. doi: 10.1007/s12253-013-9682-5. Epub 2013 Aug 6.

PMID:
23918549
27.

Secondary malignancy in patients with sporadic neuroendocrine neoplasia.

Krausch M, Raffel A, Anlauf M, Schott M, Lehwald N, Krieg A, Kröpil F, Cupisti K, Knoefel WT.

Endocrine. 2013 Oct;44(2):510-6. doi: 10.1007/s12020-013-9911-4. Epub 2013 Mar 14.

PMID:
23494366
28.

Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models.

Schäfer MK, Hartwig NR, Kalmbach N, Klietz M, Anlauf M, Eiden LE, Weihe E.

Diabetologia. 2013 May;56(5):1047-56. doi: 10.1007/s00125-013-2847-7. Epub 2013 Feb 13.

29.

Notch 1 tumor expression is lacking in highly proliferative pancreatic neuroendocrine tumors.

Krausch M, Kroepil F, Lehwald N, Lachenmayer A, Schott M, Anlauf M, Cupisti K, Knoefel WT, Raffel A.

Endocrine. 2013 Aug;44(1):182-6. doi: 10.1007/s12020-012-9850-5. Epub 2012 Dec 7.

PMID:
23225326
30.

[Neuroendocrine tumours of the GI tract--data from the German NET Registry].

Begum N, Maasberg S, Plöckinger U, Anlauf M, Rinke A, Pöpperl G, Lehnert H, Izbicki JR, Krausch M, Vashist YK, Raffel A, Bürk CG, Hoffmann J, Goretzki P, Pape UF; Weitere Vertreter des deutschen NET-Registers.

Zentralbl Chir. 2014 Jun;139(3):276-83. doi: 10.1055/s-0032-1315199. Epub 2012 Oct 5. German.

PMID:
23042103
31.

Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.

Åkerström T, Crona J, Delgado Verdugo A, Starker LF, Cupisti K, Willenberg HS, Knoefel WT, Saeger W, Feller A, Ip J, Soon P, Anlauf M, Alesina PF, Schmid KW, Decaussin M, Levillain P, Wängberg B, Peix JL, Robinson B, Zedenius J, Bäckdahl M, Caramuta S, Iwen KA, Botling J, Stålberg P, Kraimps JL, Dralle H, Hellman P, Sidhu S, Westin G, Lehnert H, Walz MK, Åkerström G, Carling T, Choi M, Lifton RP, Björklund P.

PLoS One. 2012;7(7):e41926. doi: 10.1371/journal.pone.0041926. Epub 2012 Jul 27.

32.

[Can wrist blood pressure measurement be recommended?].

Anlauf M, Tholl U.

MMW Fortschr Med. 2012 May 31;154(10):55-7. German. No abstract available.

PMID:
22803243
33.

A new procedure, but for whom?

Anlauf M, Weber F.

Dtsch Arztebl Int. 2012 Apr;109(17):313; author reply 313-4. doi: 10.3238/arztebl.2012.0313a. Epub 2012 Apr 27. No abstract available.

34.

Advanced Pancreatic Adenocarcinoma: Complete Histological Response After Palliative Therapy with Gemcitabine and Cisplatin.

Alexander A, Rehders A, Riediger R, Schmitt M, Anlauf M, Knoefel WT.

J Gastrointest Cancer. 2012 Sep;43 Suppl 1:S42-5. doi: 10.1007/s12029-012-9380-7. No abstract available.

PMID:
22528322
35.

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, Anlauf M, Wiedenmann B, Salazar R; Barcelona Consensus Conference participants.

Neuroendocrinology. 2012;95(2):157-76. doi: 10.1159/000335597. Epub 2012 Feb 15. No abstract available.

PMID:
22262022
36.

An unusual case of a retrorectal neuroendocrine tumor with high- and low-grade differentiation.

Harbeck B, Anlauf M, Klöppel G, Bröring D, Lehnert H, Mönig H.

Int J Colorectal Dis. 2012 Sep;27(9):1241-2. doi: 10.1007/s00384-011-1389-z. Epub 2011 Dec 17. No abstract available.

PMID:
22173717
37.

Coincidence of mature cystic teratoma and serotonin-producing neuroendocrine tumor of the ileum.

Krausch M, Raffel A, Anlauf M, Baldus SE, Lehwald N, Cupisti K, Eisenberger CF, Knoefel WT.

Horm Metab Res. 2011 Nov;43(12):872-6. doi: 10.1055/s-0031-1291304. Epub 2011 Nov 21.

PMID:
22105478
38.

Loss of PTEN expression in neuroendocrine pancreatic tumors.

Krausch M, Raffel A, Anlauf M, Schott M, Willenberg H, Lehwald N, Hafner D, Cupisti K, Eisenberger CF, Knoefel WT.

Horm Metab Res. 2011 Nov;43(12):865-71. doi: 10.1055/s-0031-1291333. Epub 2011 Nov 21.

PMID:
22105477
39.

Global histone modification pattern predicts poor prognosis in organic hyperinsulinism.

Raffel A, Krausch M, Roushan K, Anlauf M, Henopp T, Hafner D, Lehwald N, Kröpil F, Schott M, Eisenberger CF, Knoefel WT, Stoecklein NH.

Horm Metab Res. 2011 Nov;43(12):858-64. doi: 10.1055/s-0031-1291271. Epub 2011 Nov 21.

PMID:
22105476
40.

Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.

Anlauf M.

Horm Metab Res. 2011 Nov;43(12):825-31. doi: 10.1055/s-0031-1291307. Epub 2011 Nov 21. Review.

PMID:
22105474
41.

The immune system in neuroendocrine tumors.

Thiel A, Ehlers M, Anlauf M, Raffel A, Stoecklein NH, Schott M.

Horm Metab Res. 2011 Nov;43(12):890-6. doi: 10.1055/s-0031-1284382. Epub 2011 Oct 4. Review.

PMID:
21971962
42.

[Diagnostics and treatment in functional pancreatic neuroendocrine tumours].

Müssig K, Dudziak K, Horger M, Anlauf M, Goretzki PE.

Dtsch Med Wochenschr. 2011 Jun;136(24):1319-30. doi: 10.1055/s-0031-1280554. Epub 2011 Jun 7. Review. German.

PMID:
21656454
43.

[Pathology of neuroendocrine neoplasms].

Anlauf M, Gerlach P, Schott M, Raffel A, Krausch M, Knoefel WT, Pavel M, Klöppel G.

Chirurg. 2011 Jul;82(7):567-73. doi: 10.1007/s00104-011-2067-y. Review. German.

PMID:
21487814
44.

Increased numbers of tumor-lysing monocytes in cancer patients.

Papewalis C, Jacobs B, Baran AM, Ehlers M, Stoecklein NH, Willenberg HS, Schinner S, Anlauf M, Raffel A, Cupisti K, Fenk R, Scherbaum WA, Schott M.

Mol Cell Endocrinol. 2011 Apr 30;337(1-2):52-61. doi: 10.1016/j.mce.2011.01.020. Epub 2011 Feb 1.

PMID:
21291954
45.

Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism.

Späth M, Korovkin S, Antke C, Anlauf M, Willenberg HS.

Eur J Endocrinol. 2011 Apr;164(4):447-55. doi: 10.1530/EJE-10-1070. Epub 2011 Jan 26. Review.

46.

Induction of glutathione peroxidase 4 expression during enterocytic cell differentiation.

Speckmann B, Bidmon HJ, Pinto A, Anlauf M, Sies H, Steinbrenner H.

J Biol Chem. 2011 Mar 25;286(12):10764-72. doi: 10.1074/jbc.M110.216028. Epub 2011 Jan 20.

47.

A new mutation in the menin gene causes the multiple endocrine neoplasia type 1 syndrome with adrenocortical carcinoma.

Haase M, Anlauf M, Schott M, Schinner S, Kaminsky E, Scherbaum WA, Willenberg HS.

Endocrine. 2011 Apr;39(2):153-9. doi: 10.1007/s12020-010-9424-3. Epub 2010 Nov 11. Erratum in: Endocrine. 2011 Jun;39(3):298.

PMID:
21069576
48.

Chromogranin A as potential target for immunotherapy of malignant pheochromocytoma.

Papewalis C, Kouatchoua C, Ehlers M, Jacobs B, Porwol D, Schinner S, Willenberg HS, Anlauf M, Raffel A, Eisenhofer G, Neumann HP, Bornstein SR, Scherbaum WA, Schott M.

Mol Cell Endocrinol. 2011 Mar 15;335(1):69-77. doi: 10.1016/j.mce.2010.05.021. Epub 2010 Jun 22.

PMID:
20600588
49.

Regulation of p53 isoform expression in renal cell carcinoma.

van den Berg L, Segun AD, Mersch S, Blasberg N, Grinstein E, Wai D, Anlauf M, Gabbert HE, Mahotka C, Heikaus S.

Front Biosci (Elite Ed). 2010 Jun 1;2:1042-53.

PMID:
20515774
50.

6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.

Fottner C, Helisch A, Anlauf M, Rossmann H, Musholt TJ, Kreft A, Schadmand-Fischer S, Bartenstein P, Lackner KJ, Klöppel G, Schreckenberger M, Weber MM.

J Clin Endocrinol Metab. 2010 Jun;95(6):2800-10. doi: 10.1210/jc.2009-2352. Epub 2010 Apr 6.

PMID:
20371665

Supplemental Content

Loading ...
Support Center